A detailed history of Nuveen Asset Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 256,880 shares of KURA stock, worth $2.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
256,880
Previous 262,051 1.97%
Holding current value
$2.3 Million
Previous $5.4 Million 6.97%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.57 - $23.23 $96,025 - $120,122
-5,171 Reduced 1.97%
256,880 $5.02 Million
Q2 2024

Aug 09, 2024

BUY
$17.53 - $22.98 $909,544 - $1.19 Million
51,885 Added 24.69%
262,051 $5.4 Million
Q1 2024

May 13, 2024

BUY
$13.42 - $23.53 $144,305 - $253,018
10,753 Added 5.39%
210,166 $4.48 Million
Q4 2023

Feb 14, 2024

SELL
$7.58 - $14.38 $4.03 Million - $7.64 Million
-531,130 Reduced 72.7%
199,413 $2.87 Million
Q3 2023

Nov 14, 2023

BUY
$8.44 - $11.86 $595,737 - $837,138
70,585 Added 10.7%
730,543 $6.66 Million
Q2 2023

Aug 14, 2023

SELL
$9.62 - $13.99 $1,375 - $2,000
-143 Reduced 0.02%
659,958 $6.98 Million
Q1 2023

May 15, 2023

SELL
$10.71 - $14.6 $380,847 - $519,176
-35,560 Reduced 5.11%
660,101 $8.07 Million
Q4 2022

Feb 14, 2023

BUY
$11.23 - $16.9 $3.99 Million - $6 Million
355,277 Added 104.38%
695,661 $8.63 Million
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $1.37 Million - $2.22 Million
114,042 Added 50.38%
340,384 $4.65 Million
Q2 2022

Aug 15, 2022

SELL
$10.71 - $18.33 $3.2 Million - $5.48 Million
-298,844 Reduced 56.9%
226,342 $4.15 Million
Q1 2022

May 16, 2022

BUY
$11.78 - $16.98 $887,505 - $1.28 Million
75,340 Added 16.75%
525,186 $8.35 Million
Q4 2021

Feb 14, 2022

SELL
$12.22 - $19.57 $241,296 - $386,429
-19,746 Reduced 4.2%
449,846 $6.3 Million
Q3 2021

Nov 12, 2021

BUY
$15.42 - $21.72 $1.48 Million - $2.08 Million
95,684 Added 25.59%
469,592 $8.8 Million
Q2 2021

Aug 16, 2021

BUY
$20.85 - $29.88 $1.75 Million - $2.51 Million
83,989 Added 28.97%
373,908 $7.8 Million
Q1 2021

May 17, 2021

SELL
$24.75 - $39.14 $10.9 Million - $17.3 Million
-441,950 Reduced 60.39%
289,919 $8.2 Million
Q4 2020

May 17, 2021

SELL
$29.0 - $41.62 $678,136 - $973,242
-23,384 Reduced 3.1%
731,869 $23.9 Million
Q4 2020

Feb 16, 2021

SELL
$29.0 - $41.62 $2.38 Million - $3.42 Million
-82,199 Reduced 9.82%
755,253 $24.7 Million
Q3 2020

Nov 16, 2020

BUY
$16.3 - $30.64 $806,458 - $1.52 Million
49,476 Added 6.28%
837,452 $25.7 Million
Q2 2020

Aug 14, 2020

BUY
$7.95 - $18.81 $3.18 Million - $7.53 Million
400,579 Added 103.4%
787,976 $12.8 Million
Q1 2020

May 14, 2020

BUY
$6.45 - $14.04 $513,671 - $1.12 Million
79,639 Added 25.88%
387,397 $3.85 Million
Q4 2019

Feb 14, 2020

SELL
$12.97 - $15.94 $983,151 - $1.21 Million
-75,802 Reduced 19.76%
307,758 $4.23 Million
Q3 2019

Nov 14, 2019

BUY
$14.75 - $20.87 $4.23 Million - $5.98 Million
286,685 Added 295.93%
383,560 $5.82 Million
Q2 2019

Aug 15, 2019

BUY
$14.71 - $19.79 $1.43 Million - $1.92 Million
96,875 New
96,875 $1.91 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $598M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.